Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	18.86	19.11	16.08
Graham Fair Price	72.36	5.89	3.42
PEG	-85.50	0.06	-0.41
Price/Book	11.00	1.09	0.98
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	-62.63	11.77	31.49
Price/Sales	-44.51	0.40	0.73
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-72.44	0.06	0.24
Operating Margin	64.30	0.04	0.03
ROA	197.07	< 0.005	< 0.005
ROE	< 0.005	0.02	197.07
ROIC	< 0.005	0.03	222.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.11	4.08	-97.42
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.46	2.29	392.93
EPS QOQ	-0.77	1.99	157.64
FCF QOQ	1.00	0.00	inf
Revenue QOQ	-0.45	1.00	124.75
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	45.34	18.54	-59.12
Days Sales Outstanding (DSO)	70.26	35.12	-50.01
Inventory Turnover	1.98	4.86	144.62
Debt/Capitalization	0.39	0.42	6.12
Quick Ratio	1.12	1.12	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Positive

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	8.17	8.17	< 0.005
Cash	7.20	7.20	0.00
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	0.00	0.00
Revenue	11.02	22.04	100.04
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.59	1.59	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.02	-3.42	31.93
Naive Interpretation	Member

06 - Financial Health · Weak

Rating